Diabetic retinopathy
DR · Ophthalmology · 1 drugs · 1 indications
Microvascular damage to the retina from diabetes.
Competitive Landscape (1 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| EYLEA | REGN | VEGF trap (fusion protein) | Fusion protein | Intravitreal | APPROVED |
Indications (1)
Upcoming Catalysts
EYLEA 2mg Biosimilar Competition ImpactCOMMERCIAL
REGN2026 (ongoing)
Data from Supabase · Updated 2026-03-24